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Abstract
Differentiating somatic from emotional influences on the experience of chronic pain has been of 
interest to clinicians and researchers for many years. Although prior research has not well 
specified these pathways at the anatomical level, some evidence, both theoretical and empirical, 
suggest that emotional reactions influence the experience of disease and non-disease-related pains. 
Other studies suggest that treatments directed at negative emotional responses reduce suffering 
associated with pain. The current study was conducted to explore the influence of emotional 
reactions to pain as a predictor of psychological distress in a sample of adult Blacks with Sickle 
Cell Disease (SCD). Using cross-sectional survey data, we evaluated whether negative emotional 
reactions to the experience of pain were predictive of psychological distress after controlling for 
the somatic dimension of pain and age in n = 67 Black patients with Sickle Cell Disease (SCD). 
Results showed that greater negative emotion associated with pain predicted Somatization (p < .
01), Anxiety (p < .05), Phobic Anxiety (p < .05), and Psychoticism (p < .05). Increased negative 
emotion associated with pain was also predictive of the General Symptoms Index (p < .05) and the 
Positive Symptoms Total from the SCL-90-R (p < .01). We believe the current study demonstrates 
that negative emotional reactions to the experience of pain in adults with SCD are predictive of 
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psychological distress above and beyond the influences of age and the direct nociceptive 
experience. We also believe these data to be valuable in conceptualizing the allocation of 
treatment resources toward a proactive approach with early identification of patients who are 
responding poorly for the purpose of potentially reducing later psychopathology. A deeper 
understanding of the ways that subpopulations cope with chronic disease-related pain may 
produce models that can be ultimately generalized to the consumers of the majority of healthcare 
resources.
Keywords
depression; pain; negative emotional reactions; sickle cell disease
INTRODUCTION
Chronic pain remains one of the more poorly understood phenomena in medical and social 
science research. Although pain is the single most common reason to visit a physician [1, 2] 
and one of the most common reasons patients seek medical care [3], there remains 
controversy over the biological, psychological, and social basis of chronic pain. Many 
clinicians and scientists continue to debate the existence, for example, of fibromyalgia, 
chronic fatigue syndrome, and myofascial pains as manifestations of mental illnesses rather 
than physical disorders or biological syndromes [4]. Patients with these conditions often 
present with debilitating primary effects under conditions of unclear etiology and powerful 
secondary effects that can alter emotional states and facilitate misdiagnosis [5].
When present in patients with chronic pain, psychological symptoms such as depressed 
mood or elevated anxiety can be even more perplexing and difficult to identify due to their 
comorbidity and shared symptomatology [6–9]. Commonly shared symptoms of pain and 
depression, for example, include but are not limited to sleep and appetite disturbances, 
fatigue, reduced behavioral activity with anhedonia, social withdrawal, changes in weight, 
and decreased libido [10–12]. These depressive symptoms are less likely to be recognized 
by clinical providers when primary complaints are pain-related [13]. Many patients with 
chronic pain experience an increased prevalence of psychosocial crises that include job loss, 
the loss of roles in the family system, decreases in social functioning, and increased 
healthcare costs [14]. This shift in functioning and resource utilization can also be associated 
with depressive symptomatology [15]. Conversely, patients with depression may present 
with emotional symptoms [15] and painful somatic symptoms including, headaches [16], 
muscle aches, and backaches [17].
Negative mood states and stress predict physical symptoms of pain-related illnesses and vice 
versa (e.g., arthritis, irritable bowel syndrome, and recurrent abdominal pain in children) 
[17]. Studies have shown that fluctuations in negative mood and stress predict not only pain, 
but also psychosocial and functional outcomes [2, 5]. Clinicians and researchers alike have 
speculated that psychological disorders, such as depression or anxiety, can be associated 
with the onset of painful episodes in diseases like sickle cell disease (SCD), a class of 
inherited blood disorders (e.g., sickle cell anemia, sickle hemoglobin C, sickle beta 
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thalassemia) characterized by a decreased quantity of red-blood cells capable of effectively 
carrying oxygen as a result of their shortened lifespan and sickled shape. Previously, this 
speculation was supported by predominately anecdotal evidence and retrospective studies 
[2]. However, in recent years, several investigations have provided evidence for a 
relationship between mood, stress, and pain in patients with SCD [6–8, 18]. To our 
knowledge, none of these previous studies have examined the impact of negative emotional 
responses to the experiences of chronic pain as the basis of the prediction of clinically 
relevant psychiatric dispositions in adult patients with SCD.
There is evidence of substantial variability in the presentation of negative mood symptoms, 
among ethnic groups and across cultures, but few if any of these models have been used as 
the basis of a study in a sample of Blacks [19–21]. The majority of patients with SCD in the 
United States are Black, have chronic pains, generally present with a high incidence and 
prevalence of psychopathology [7, 22–30], and are an ideal sample for such a study.
In the context of a general literature that documents the impact of pain on mood (2, 5, 17), 
and in the absence of findings in samples of Blacks with SCD, we asked: Can emotional 
reactions to pain in patients with SCD be used to predict differences in the magnitude of 
psychological distress? The primary aim of this study was to investigate the predictive value 
of the negative emotional dimension of pain on the magnitude of psychological distress in 
patients with SCD. We hypothesized that negative emotional reactions to pain would be 
significantly predictive of psychological distress in this population.
METHODS
Study Design
The current study represents a cross-sectional evaluation of data collected as part of a 
longitudinal investigation of the relationship of medical and psychosocial factors to pain in 
patients with SCD.
Participants
Participants were 67 adult patients diagnosed with SCD from the Duke University 
Comprehensive Sickle Cell Center. Inclusion criteria included a diagnosis of SCD provided 
by the study hematologist. Participants were excluded from the study if they were actively in 
an acute episode of pain or other urgent medical crisis at the time of clinic visit or if they 
were unable to read and comprehend the written instructions for testing. Patients were also 
excluded from analysis if they had a significant diagnosis other than SCD (e.g., history of 
psychotic episode in the past 6 months). The consent form and all study procedures were 
approved by the institutional review board at Duke University Medical Center.
Materials
Pain—The Short Form McGill Pain Questionnaire (SF-MPQ) [31] and a visual analogue 
scale were used to measure pain severity. The SF-MPQ is structured to assess qualitative 
and quantitative aspects of pain including location, intensity, quality, and temporal 
dimensions. Participants were asked to rate the current intensity of each pain-related 
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adjective by circling “none, mild, moderate, or severe.” The measure has demonstrated 
validity and reliability with multiple pain populations. Intra-class correlations, as estimates 
of reliability, for the sensory, affective, and average pain scores, are 0.96, 0.95, 0.88, and 
0.89, respectively [32]. There is a very high correlation between scales of the long and short-
forms of the McGill Pain Questionnaire.
Psychopathology—The Symptoms Checklist 90-items, Revised (SCL-90-R) [33] was 
used to evaluate the magnitude of common psychopathologies including Somatization 
(SOM; distress arising from perceptions of bodily dysfunctions), Obsessive-compulsion (O-
C; irresistible thoughts, behaviors, or impulses), Interpersonal Sensitivity (I-S; feelings of 
personal inadequacy or uneasiness), Depression (DEP; dysphoric mood and other symptoms 
associated with depression), Anxiety (ANX; a tendency toward anxiety as manifest by 
nervousness, tension, and trembling), Phobic Anxiety (PHOB; a persistent fear response to a 
specific person, place, object, or situation), Hostility (HOS; thoughts, feelings, or actions 
that are associated with a state of anger), Paranoia (PAR; suspiciousness or the fear of loss 
of autonomy), and Psychosis (PSY; the perception of unusual experiences or interpersonal 
isolation). The SCL-90-R also has 3 global indices including General Severity Index (GSI; 
the current level and depth of negative emotional distress), Positive Symptom Distress Index 
(PSDI; intensity of symptoms as a function of the number of endorsed symptoms), and the 
Positive Symptom Total (PST; number of symptoms that patients endorse). Response 
options range from 0 (not at all) to 4 (extremely). Internal consistency for the subscales 
ranged from .77 to .90. Cronbach alphas for the global severity index (GSI) are high, 
ranging between .96 and .97 [33].
Social Desirability—The Marlow-Crowne Social Desirability Scale (MCSD) is often 
incorporated in studies to account for a study subject’s tendency to respond to questions in a 
culturally desirable manner within the context of a current ethnic-cultural population under 
study. The original instrument was developed by Marlow and Crowne in 1960 [34]. The 
scale presents culturally approved behaviors with a low probability of occurrence. Higher 
scores represent an increased tendency to answer questions according to what the participant 
believes would likely please the proctor. Kuder-Richardson coefficient of internal 
consistency is .88 with a one-month test-retest correlation of .89.
Procedures
Study procedures have been described previously [6, 7, 22, 35]. Briefly, all patients were 
consented and enrolled individually in the current study during routine visits to the Duke 
University Comprehensive Sickle Cell Center. Patients were identified by the study 
hematologist as suitable for participation based upon the patient’s ability to read, and their 
characteristics matched against inclusion and exclusion criteria. They were then approached 
by study personnel about participation. All patients were given a brief verbal overview of 
the study, which included conducting a review of their historical patterns of healthcare 
utilization from their medical records, and then allowed to read the consent forms.
Participants were then provided a copy of the survey, moved to a relatively quiet or isolated 
portion of the waiting room when possible, and given instructions for completion of the 
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survey by a member of the study team. Once complete, the survey was collected and an 
informal debriefing was provided.
Statistical Analyses—Statistical analyses were conducted using SAS [36]. Data were 
examined for normality, homoscedasticity, skewedness, kurtosis, and multicollinearity prior 
to analysis. The primary data analysis strategy was to conduct separate regression analysis 
models on the nine symptom scales and three global indices of the SCL-90-R. Following 
adjustment for age, the Sensory and Affective scales of the McGill Pain Questionnaire–
Short Form were entered into the models to predict outcomes on the SCL-R-90.
RESULTS
Participants
Sixty-seven participants (n = 30 male and n = 37 female), mean age 36.82 ± 11.47 (range 
18–70), mean years of education 13.28 ± 1.84 completed the assessment during the first year 
of evaluation. Thirty-two percent of patients were married, 48% were single, 17% were 
divorced/separated, and 3% were living with a significant other. Sixty-four percent of 
patients were employed at the time of assessment. Twenty-nine percent of patients reported 
that they had experienced “Anxiety,” and 36% indicated that they had experienced 
“Depression” in the 30 days prior to assessment. Patients who endorsed these psychological 
symptoms did not differ in their age, education, tendency to report in a socially desirable 
manner, or reports of pain from patients who did not endorse the presence of these 
symptoms.
Zero-Order Correlations between Predictor and Outcome Variables
Generally, there were high intercorrelations among scales of the SCL-90-R (p < .001; Table 
1). Further, the negative emotional dimension of pain was significantly positively correlated 
(p < .05) with all scales of the SCL-90-R except for Hostility (p > .05). The SCL-90-R 
scales were less strongly correlated with age and the sensory dimension of pain. Age was 
significantly positively correlated with Interpersonal Sensitivity (p < .05) and Hostility (p < .
05), while the Sensory experience of pain was significantly positively correlated with SOM, 
O-C, I-S, DEP, ANX, and PSY symptom scales, well as the GSI, PSDI, and PST (p < .05). 
Social desirability was unrelated to any of the study variables.
Association between Negative Emotional Responses and Psychopathology
After covarying for age and the sensory dimension of pain, the negative emotional 
dimension of pain was found to be significantly associated with SOM (F[3, 62] = 7.75, p < .
01, R2 = 0.27) and ANX (F[3, 62] = 5.39, p < .01, R2 = 0.21). In addition, the negative 
emotional dimension of pain was also found to be significantly associated with PHOB (F[3, 
62] = 2.86, p < .05, R2 = 0.12), and PSY (F[3, 62] = 4.88, p < .01, R2 = 0.19). Lastly, the 
negative emotional dimension of pain was predictive of the GSI (F[3, 62] = 6.72, p < .001, 
R2 = 0.25) and the PST (F[3, 62] = 6.81, p < .001, R2 = 0.25). Regression coefficients are 
presented in Table 2. The negative emotional dimension of pain was not predictive of the O-
C, I-S, DEP, HOS, or PAR symptom scales as well as the PSDI.
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To our knowledge, this is one of only two studies to evaluate the relationship between 
negative emotional reactions to pain and subsequent psychological outcomes in adult 
patients with SCD. Previous studies have identified the somatic experience of pain as 
significant in predicting negative emotional states, healthcare utilization, and quality of life 
[37]. We extended these previous findings to include that the negative emotional reaction to 
the somatic experience of pain, controlling for the magnitude of nociceptive experience, was 
predictive of psychological distress which included anxiety about health and other issues, 
elevated levels of distrust, and the increased belief that one is isolated by experiences that 
are disparate from the general population. Negative emotional reactions to pain were also 
predictive of the number of symptoms endorsed by patients who have SCD, and the level 
and depth of negative emotional distress.
These results are consistent with past studies in other populations that have found a 
relationship between psychological symptoms and the experience of chronic pain in patients 
with SCD [7, 22, 32, 35, 38]. Pain perception and psychological disposition are intricately 
intertwined, with one affecting the other. More broadly, the experience of pain influences 
and is influenced by biological, cognitive, and emotional processes all experienced in a 
social context [25, 35, 39, 40]. Our study suggests that beyond previous findings, negative 
affective reactions to pain, independent of the magnitude of the somatic experience, are 
predictive of a range of anxieties and fears, and even the magnitude of symptoms reported 
by patients.
Beyond previous studies, however, the current results highlight the need to better resource 
patients with SCD to manage and control their responses to pain as a way of possibly 
reducing later psychological distress. For example, it is possible that patients who have 
access to care providers and well-defined plans for responses when painful crises arise may 
respond differently and with greater anxiety and fear than patients without such resources. In 
the current model, such reaction may be associated with later and more complicated 
negative psychological consequences. In essence, the nature, unpredictability, and intensity 
of pains in adult patients with SCD may produce a more intense and debilitating overall 
experience, and potentially more affective morbidities among patients who view and then 
respond to their disease state as negative. Previous studies, in non-SCD samples, have 
demonstrated that individuals who experience intense physical pain are more likely to 
endorse and experience high levels of psychological distress and vice versa [41, 42]. These 
models should increasingly be applied to understanding reactions to SCD pain and related 
psychopathology.
We also found that the tendency to ruminate and obsess, to be overly sensitive to the 
opinions of others, and the tendency to be sad or hostile were not predicted by negative 
reactions to experience of pain. Unfortunately, the current state of the pain literature does 
not provide substantial guidance to interpret these findings. For example, some studies 
indicate that emotionally disturbed individuals report higher pain intensities then their 
healthier counterparts; whereas other studies have shown that individuals with negative 
emotional disturbance have high thresholds and tolerances for pain [43, 44]. We do, 
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however, believe that further research will begin to elucidate the complicated relationship 
between negative emotional reactions to pain and subsequent psychopathology in patients 
with SCD.
We recognize that many scientists conceptualize behavioral manifestations of negative 
emotional states like hostility as the product of cognitive processes like rumination among 
patients with pain [45, 46]. These manifestations are subsequently the products of 
multidimensional social, interpersonal, psychological, and biological factors (e.g., anger, 
negative perception, cynicism, appraisals concerning others, etc.) that are differentially 
experienced and coped with [2, 6, 22, 47–54] across racial, ethnic, age, gender, and other 
demographic characterizations [21, 35, 39] as well as genetic predispositions [9]. Better 
understanding the interaction of such factors with reports of acute and chronic pain is a 
growing mission for many clinical and academic researchers. Additional prospective 
investigations are needed, if the desire is to better understand what is unique about these 
relationships among patients with SCD and why they are not predicted by emotional 
reactions as are other related variables.
Limitations
The primary limitation to the current study is the modest sample size within a limited sample 
of adult patients with SCD. This limitation precluded a substantial increase in N for 
potentially more power, and limited extensive exploration of the influence of additional 
demographic factors on outcome variables of interests. We did not present power analyses in 
the current article, particularly because we were adequately powered to see significance in a 
majority of analyses that we conducted and presented in the Results section.
Secondarily, the authors acknowledge that reactions to acute episodes of pain may 
substantially differ from reactions to a more non-crisis chronic pain. For example, the degree 
to which patients are likely to catastrophize in response to a sudden and acute episode of 
acute pain may differ substantially as compared to their reactions to a more chronic familiar 
pain. The primary role of factors that have historically been associated with explaining such 
differences in reactions to acute and chronic pain in the general population are largely 
unexplored in patients with SCD. We also note that there may be little difference between 
multiple and repeated acute episodes of pain across a lifespan and a single chronic enduring 
(chronic) pain. Hence, we view the study of chronic pain in patients with SCD as a stable 
and reliable indicator of nociceptive experience, and likely the best estimate of disability. 
We note that future studies must begin to better understand the difference between a repeat 
acute pain over time and a chronic pain, and the impact of the difference, if it exists, on 
disability and functionality.
We view better understanding these factors as legitimate and necessary for future studies. 
Although negative emotion and other cognitive behavioral factors have been shown to 
independently predict increased reports of pain and psychosocial dysfunction among 
patients with SCD [55–58], a substantial amount of the variance is still left unexplained 
suggesting that further exploration is warranted.
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We view our study as the impetus for additional rigorous prospective exploration. No 
previous studies have explored the impact of negative reactions to pain in the manifestation 
of clinically relevant psychiatric dispositions in adult patients with SCD. We view this study 
as a very important first step toward characterizing reactions to SCD-related pain on risk for 
psychopathology in adults.
Lastly, the current study demonstrates that, in a sample of Black adults with SCD, the initial 
emotional reactions to pain predict longer-term psychological distress independent of age. 
We believe that the model established by this study should be replicated and has the 
potential to elucidate the important role that psychological distress has on opiate utilization 
patterns, dyspnea, sleep dysfunction, and other clinical outcomes among patients with SCD 
in the United States and around the world [59–67].
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Table 2
Association between Negative Emotional Responses to Pain and Psychiatric Outcomes
SCL-90-R Outcomes Predictors B S.E.
Somatization (SOM) Age −7.06* 3.08
Sensory .073 0.22
Affective 1.29** 0.47
Anxiety (ANX) Age −7.79 4.19
Sensory .11 0.29
Affective 1.43* 0.65
Phobic Anxiety (PHOB) Age −3.63 3.37
Sensory −.09 0.24
Affective 1.11* 0.52
Paranoid Ideation (PAR) Age −2.69 3.49
Sensory −.13 0.24
Affective 1.08† 0.54
Psychoticism (PSY) Age −7.70 4.03
Sensory .06 0.28
Affective 1.34 0.62
Depression (DEP) Age −6.95 4.11
Sensory .21 0.29
Affective .87 0.63
Hostility (HOS) Age −8.14* 3.83
Sensory .06 0.27
Affective .66 0.59
Obsessive-Compulsive (O-C) Age −3.48 3.64
Sensory .15 0.25
Affective .92 0.56
Interpersonal Sensitivity (I-S) Age −9.53 3.87
Sensory .17 0.27
Affective .90 0.60
General Severity Index (GSI) Age −8.25* 3.80
Sensory .13 0.27
Affective 1.40* 0.59
Positive Symptom Distress Index (PSDI) Age −6.13 3.44
Sensory .15 0.24
Affective .86 0.53
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